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Abstract 
The list of doping agents is enormous, and for the majority, any beneficial sporting effect is contentious. WADA 
and UK Anti-Doping have difficulty detecting the peptide hormones, Growth Hormone (GH). insulin and Erythropoietin 
(Epo), because they require blood analysis. Only in the last two years has an athlete been convicted of taking GH, 
which is still being used as a doping agent because the window for detection is so brief. This positive test was not 
contested, which suggests that science may be winning the war on drugs. Athletes appear to have ceased taking 
insulin, because of its life-threatening acute effects, and in recent years no adverse analytical findings have been 
reported for this drug. 
"Older" doping agents, which are known to enhance performance in sport, include testosterone and their 
derivatives, anabolic steroids. 
The pharmaceutical industry continues to manufacture new medicines, pushing back the boundaries in combating 
wasting disease states and the ageing process, but is inadvertently producing the latest generation of doping agents. 
This wilt challenge anti-doping scientists. 
WADA's banned list also includes insulin-like growth factor-1, fibroblast growth factors, hepatocyte growth factor, 
mechano growth factors, platelet-derived growth factor, vascular-endothelial growth factor which may promote muscle, 
tendon or ligament development, vascularisation, energy utilisation, regenerative capacity and fibre type. Athletes will 
use whatever they believe works, but can only use what is available. Internet companies offer these anabolic products 
that but their veracity cannot be proven. 
There are questions that need to be answered? Are these products available to athletes, do they enhance 
performance, are athletes really taking them and are they so difficult to detect. The internet has made them available 
to anyone with a credit card and it appears that if they are cycled correctly, unless an athlete is caught in possession 
of them, the opportunity of proving a case of doping is almost impossible. 
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Introduction 
The involvement of sport's scientists in elite sport has led them 
to develop improved nutrition, physiological and psychological 
techniques but also to be significantly implicated in the development 
and use of performance enhancing drugs [l]. East German scientists 
were involved in the state-sponsored systematic doping of athletes 
in the former East Germany [2]. American scientists have also been 
concerned in the dissemination of performance and image enhancing
drugs used in international sport. Dr John Ziegler, originally developed 
the Androgenic Anabolic Steroid (AAS) Methandrostenolone 
(Dianabol) which was released in the USA in 1958 by the pharmaceutical 
giant, Ciba. Ziegler pioneered its athletic use as an aid to muscle growth 
by bodybuilders, administering it to USA weightlifting champion Bill 
March in 1959 when he was the physician to the USA Weightlifting 
team [3]. This appears to be the first documented use of AAS in sport 
[4]. The emphasis and rewards placed on winning and breaking world 
records has made this liaison between sporting performance and 
science almost inextricable. 
In 1960, Danish cyclist, Knut Jensen, was the first athlete to die in 
Olympic competition due to doping, during the 100 km team time trial 
race. His autopsy revealed traces of amphetamine [5]. British cyclist 
Tom Simpson, whose motto was "if it takes ten to kill you, take nine 
and win ..... " was the first death caused by doping in the Tour de France, 
in 1967. Two tubes of amphetamines and a further empty tube were 
found in the rear pocket of his racing jersey. His autopsy revealed traces 
of amphetamine, alcohol and the diuretic frusemide. 
In 1967 to combat doping, the International Olympic Commitee 
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(IOC) established a Medical Commission which provided three 
fundamental principles: protection of the health of athletes, respect for 
medical and sport ethics, and equality for all competing athletes [ 6]. 
At that time the list of banned substances included narcotic 
analgesics, stimulants and alcohol. Although it was suspected that 
AAS were being used at this time, testing methods were insufficiently 
developed to warrant their inclusion. The first compulsory doping 
controls were at the Winter Olympic Games in Grenoble, France in 
1968 [7]. 
In the 1984 Olympics, some team doctorswere involved inexploiting 
the doping regulations. Team doctors had to fill in declarations for all 
athletes using specific drugs perceived to be performance enhancing. If 
competitors produced a doctor's certificate stating that they needed a 
drug for health reasons, they would not be disqualified, if drug checks 
proved positive. Following a large number of positive urinalyses some 
teams provided medical certificates covering the whole team [8]. This 
identified the deception that physicians were prepared to be concerned 
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